Category: Federal Forum Posters
Purpose: Sexually transmitted diseases (STD) place a significant economic burden on the healthcare system. Patients infected with an STD are also at an increased risk of being infected with the Human Immunodeficiency Virus (HIV). In June 2018, the Michael E. DeBakey Veterans Affairs Medical Center instituted an Infectious Diseases Pharmacist STD culture review service. The purpose of this project is to evaluate the impact of a pharmacist-managed STD culture review on the time to intervention, appropriateness of prescribed treatments and to inform the educational
Methods: All patients with a positive chlamydia, gonorrhea or syphilis test result will be identified using Theradoc, a clinical surveillance software. A prospective review of all positive chlamydia, gonorrhea and syphilis test results will be conducted using the VA Computerized Patient Record System. A chart review will be conducted to evaluate the need for additional laboratory tests and to determine the appropriate treatment. The PCP will be notified with treatment recommendations and the need to order more laboratory tests if necessary.
The ID Pharmacy Service will also place orders for treatment as appropriate. Patient risk factors will also be assessed to determine the appropriateness of HIV Pre-Exposure Prophylaxis (PrEP). The primary objective of the project is to evaluate time to intervention and the appropriateness of the treatment before (September 2017 to February 2018) and after (September 2018 to February 2019) the implementation of the pharmacist-managed STD culture review.
The project will also evaluate time to ordering of follow-up labs, proportion of patients enrolled in the PrEP clinic, and new HIV diagnosis within 3 months of treatment. Descriptive statistics and the student’s t-test will be used to analyze the outcomes of the project.
Yewande Dayo– PGY2 Infectious Disease Pharmacy Resident, Michael E. DeBakey VA Medical Center, Houston, TX